Evaluation of the clinical safety of desmopressin during pregnancy in women with a low plasmatic von Willebrand factor level and bleeding history

Saved in:

Bibliographic Details
Published in	Thrombosis research Vol. 120; no. 3; pp. 387 - 390
Main Authors	Sánchez‐Luceros, Analía, Meschengieser, Susana S., Turdó, Karina, Arizó, Adriana, Woods, Adriana I., Casais, Patricia, Blanco, Alicia N., Kempfer, Ana C., Lazzari, María A.
Format	Journal Article
Language	English
Published	New York, NY Elsevier Ltd 01.01.2007 Elsevier Science
Subjects	Adolescent Adult Biological and medical sciences Blood and lymphatic vessels Blood Coagulation Disorders - diagnosis Blood Coagulation Disorders - prevention & control Blood. Blood coagulation. Reticuloendothelial system Cardiology. Vascular system Cohort Studies Coronary heart disease Deamino Arginine Vasopressin - adverse effects Deamino Arginine Vasopressin - therapeutic use Desmopressin Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Drug Evaluation Factor VIII - metabolism Female Heart Hematology, Oncology and Palliative Medicine Hemostatics - adverse effects Hemostatics - therapeutic use Humans Medical sciences Pharmacology. Drug treatments Pregnancy Pregnancy Complications, Cardiovascular Pregnancy Outcome Pregnancy Trimester, Third Retrospective Studies von Willebrand factor von Willebrand Factor - genetics von Willebrand Factor - metabolism Women Women Pregnancy Desmopressin von Willebrand factor Human Peptides Antidiuretic Neurohypophyseal hormone Cardiovascular disease Willebrand factor Hemorrhage
Online Access	Get full text
ISSN	0049-3848 1879-2472
DOI	10.1016/j.thromres.2006.09.004

Cover

More Information
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0049-3848 1879-2472
DOI:	10.1016/j.thromres.2006.09.004